Viewing Study NCT00513851


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-04 @ 5:08 PM
Study NCT ID: NCT00513851
Status: COMPLETED
Last Update Posted: 2011-09-27
First Post: 2007-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of OSI-930 in Cancer Patients
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module